MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$4,276,956
Net Income
-$1,069,888
Net Profit Margin
-25.02%
EPS
-$0.046
Unit: Dollar
Revenue Breakdown
Technology Fees
Device Sales
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
4,276,956
4,250,632
3,987,819
3,885,795
Cost of revenue
746,136
851,608
736,343
704,297
Gross profit
3,530,820
3,399,024
3,251,476
3,181,498
Selling, general and administrative expenses
2,699,308
1,862,798
2,186,994
2,304,881
Research and development expenses
673,444
841,669
623,567
602,798
Total operating expenses
3,372,752
2,704,467
2,810,561
2,907,679
Income (loss) from operations
158,068
694,557
440,915
273,819
Other income/(expense) note 3
40,904
25,955
-39,247
106,599
Interest expense
851,753
840,938
810,339
860,419
Loss/(gain) upon convertible promissory notes conversion and redemption note 8
-
0
11,409
-
Accretion and amortization expenses
-196,636
-204,713
-185,470
-202,141
Change in fair value of derivative liabilities note 8
-110,051
957
-134,335
-8,771
Net loss before income taxes
-959,468
-324,182
-717,067
-690,913
Net loss before dividends
-959,468
-324,182
-717,067
-690,913
Preferred stock dividends
110,842
129,593
431,000
81,410
Net loss attributable to common stockholders
-1,070,310
-453,775
-1,148,067
-772,323
Translation adjustment
422
5,883
-14,547
9,286
Comprehensive loss
-1,069,888
-447,892
-1,162,614
-763,037
Basic EPS
-0.046
-0.016
-0.042
-0.029
Diluted EPS
-0.046
-0.016
-0.042
-0.029
Basic Average Shares
23,096,373
28,574,398
27,590,766
26,767,370
Diluted Average Shares
23,096,373
28,574,398
27,590,766
26,767,370
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$1,069,888
(-35.35%↓ Y/Y)
Translation adjustment
$422
(101.17%↑ Y/Y)
Technology Fees
$4,166,401
(23.58%↑ Y/Y)
Device Sales
$110,555
(-78.00%↓ Y/Y)
Net loss
attributable to common...
-$1,070,310
(-41.90%↓ Y/Y)
Revenue
$4,276,956
(10.40%↑ Y/Y)
Net loss before
dividends
-$959,468
(-42.78%↓ Y/Y)
Preferred stock dividends
$110,842
(34.65%↑ Y/Y)
Gross profit
$3,530,820
(13.28%↑ Y/Y)
Cost of revenue
$746,136
(-1.46%↓ Y/Y)
Net loss before
income taxes
-$959,468
(-42.78%↓ Y/Y)
Income (loss) from
operations
$158,068
(-43.94%↓ Y/Y)
Other
income/(expense) note 3
$40,904
(-38.65%↓ Y/Y)
Total operating
expenses
$3,372,752
(18.97%↑ Y/Y)
Interest expense
$851,753
(0.18%↑ Y/Y)
Accretion and
amortization expenses
-$196,636
(-28.04%↓ Y/Y)
Change in fair value of
derivative liabilities...
-$110,051
(-336.71%↓ Y/Y)
Selling, general and
administrative expenses
$2,699,308
(26.21%↑ Y/Y)
Research and development
expenses
$673,444
(-3.26%↓ Y/Y)
Buy us a coffee
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)